| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/30/2013 | WO2013041730A8 Serum half-life extension using immunoglobulin binding domains |
| 05/30/2013 | WO2013038272A3 Streptavidin mutein exhibiting reversible binding for biotin and streptavidin binding peptide tagged proteins |
| 05/30/2013 | WO2012175153A3 Stable aqueous protein solution or protein dispersion, method for the production thereof, and use thereof |
| 05/30/2013 | WO2012130221A4 Means for treating microbial diseases in cultivated plants |
| 05/30/2013 | WO2012101156A3 Human lactoferrin based peptides having antiinflammatory activity |
| 05/30/2013 | US20130139284 Plants and Polynucleotides Encoding Truncated Cry34 Proteins |
| 05/30/2013 | US20130139279 Wuschel (wus) gene homologs |
| 05/30/2013 | US20130139274 B-cell stimulating fusion proteins of an antigen with baff or april |
| 05/30/2013 | US20130137859 Methods of crystallising perforin |
| 05/30/2013 | US20130137858 Immobilized proteins and methods and uses thereof |
| 05/30/2013 | US20130137758 Akt activity specifically inhibiting polypeptide |
| 05/30/2013 | US20130137636 Recombinant human follicle-stimulating hormone |
| 05/30/2013 | US20130137633 mTOR KINASE-ASSOCIATED PROTEINS |
| 05/30/2013 | US20130137631 Gip analog and hybrid polypeptides with selectable properties |
| 05/30/2013 | US20130137628 Dimeric Oxidation-Resistant Apolipoprotein A1 Variants |
| 05/30/2013 | US20130137187 Synthetic active peptide fragments |
| 05/30/2013 | US20130137161 Nucleotide-Specific Recognition Sequences For Designer TAL Effectors |
| 05/30/2013 | US20130137160 Nucleotide-Specific Recognition Sequences For Designer TAL Effectors |
| 05/30/2013 | US20130137118 Integrin heterodimer and a subunit thereof |
| 05/30/2013 | US20130137106 Tumor Marker and Methods of Use Thereof |
| 05/30/2013 | US20130136764 Preparation of conjugates comprising adenine derivatives and allergenic proteins and their use for specific immunotherapy of allengenic diseases |
| 05/30/2013 | US20130136763 Methods Of Treatment With Compositions That Include Hemagglutinin |
| 05/30/2013 | US20130136762 Modified surface antigen |
| 05/30/2013 | US20130136761 S. pneumoniae antigens |
| 05/30/2013 | US20130136760 Streptococcus pyogenes antigens and corresponding dna fragments |
| 05/30/2013 | US20130136759 Anti-rsv immunogens and methods of immunization |
| 05/30/2013 | US20130136747 Anti-amyloid beta antibodies and their use |
| 05/30/2013 | US20130136745 Soluble endoglin and uses thereof |
| 05/30/2013 | US20130136741 Novel Enhanced Selectin Antagonists |
| 05/30/2013 | US20130136739 Methods of use of soluble cd24 for therapy of rheumatoid arthritis |
| 05/30/2013 | US20130136718 Targeting interferon-lambda with antibodies potently enhances anti-tumor and anti-viral activities |
| 05/30/2013 | US20130136692 Molecular signature of cancer |
| 05/30/2013 | US20130135979 Composition comprising various proteorhodopsins and/or bacteriorhodopsins and use thereof |
| 05/30/2013 | CA2856255A1 Recombinant proteins and their therapeutic uses |
| 05/30/2013 | CA2856017A1 Engineered stem cells and their therapeutic use |
| 05/30/2013 | CA2855139A1 Fibrinogen assay |
| 05/30/2013 | CA2854255A1 Mutations of histone proteins associated with proliferative disorders |
| 05/30/2013 | CA2852389A1 Plants having enhanced yield-related traits and method for making the same |
| 05/29/2013 | EP2597151A2 Recombinant microorganisms, methods for preparing vaccine strains, antigens, and vector vaccine compositions of same, uses thereof, and related antibodies, diagnostic kit, and treatment and/or prophylactic methods |
| 05/29/2013 | EP2597105A1 A conjugate comprising angiostatin or its fragment, the method for producing the conjugate and use thereof |
| 05/29/2013 | EP2597103A1 Pharmaceutical compositions containing insulin and an insulinotropic peptide |
| 05/29/2013 | EP2597102A1 A novel fusion protein comprising an antibody light chain and a polypeptide binding to IL-17 |
| 05/29/2013 | EP2596801A1 Methods for treating cancer with mva |
| 05/29/2013 | EP2596799A1 Methods and compositions related to inhibition of viral entry |
| 05/29/2013 | EP2596706A1 Method for increasing thermal hysteresis activity, method for reducing thermal inactivation of thermal hysteresis activity, and composition for increasing thermal hysteresis activity |
| 05/29/2013 | EP2596368A2 Improving the efficiency of prion conversion in vitro and sensitivity of prion detection |
| 05/29/2013 | EP2596102A2 Sequence specific double-stranded dna/rna binding compounds and uses thereof |
| 05/29/2013 | EP2596023A2 Compositions and methods featuring il-6 and il-21 antagonists |
| 05/29/2013 | EP2596016A1 Intracellular immunity |
| 05/29/2013 | EP2596014A1 Manufacture of inter -alpha - inhibitor proteins (iaip) from plasma |
| 05/29/2013 | EP2596013A1 Nkx2.2 inhibitors as drugs |
| 05/29/2013 | EP2596012A2 Plant cytochrome p450 |
| 05/29/2013 | EP2596011A2 Methods and compositions for modification of a hla locus |
| 05/29/2013 | EP2596010A2 Signal biomarkers |
| 05/29/2013 | EP2595648A2 Novel long-acting glucagon conjugate and pharmaceutical composition comprising the same for the prevention and treatment of obesity |
| 05/29/2013 | EP2595645A2 Use of amino acid sequences from mycobacterium tuberculosis or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom |
| 05/29/2013 | DE102004013826B4 Hyphenspezifische Zellwandproteine in Candida Hyphenspezifische cell wall proteins in Candida |
| 05/29/2013 | DE10017526B4 Standardprotein Standard protein |
| 05/29/2013 | CN1813061B Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| 05/29/2013 | CN1661014B Novel method to isolate mutants and to clone the complementing gene |
| 05/29/2013 | CN1525866B Treatment using neublastin polypeptides |
| 05/29/2013 | CN103124784A Method for expansion of stem cells and the use of such cells |
| 05/29/2013 | CN103124740A Anti-SSX-2 T cell receptors and related materials and methods of use |
| 05/29/2013 | CN103124739A Novel glucagon like peptide analogs, composition, and method of use |
| 05/29/2013 | CN103124738A Glucosinolate transporter protein and uses thereof |
| 05/29/2013 | CN103124737A Immunogenic composition or vaccine against Gram-negative bacterial, for example neiserial, infrection or disease |
| 05/29/2013 | CN103124562A FGF21 analogues and derivatives |
| 05/29/2013 | CN103122351A Mutational saccharomyces cerevisiae starting transcription factor gene as well as expression vector and application thereof |
| 05/29/2013 | CN103122031A Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 05/29/2013 | CN103122030A Hirulog as well as preparation method and application thereof |
| 05/29/2013 | CN103122029A Method for purifying human recombinant SPINK6 protein with KLK14 protein through affinity chromatography |
| 05/29/2013 | CN103122028A Method for purifying human recombinant SPINK6 protein with trypsin through affinity chromatography |
| 05/29/2013 | CN103122027A Recombinant human collagen and production method thereof |
| 05/29/2013 | CN103122026A Solid-phase preparation method for exenatide crude product |
| 05/29/2013 | CN103122025A Small molecule-polypeptide conjugate for inhibiting human immunodeficiency virus (HIV) infection |
| 05/29/2013 | CN103122024A Artificially designed HIV (human immunodeficiency virus)-infection-resisting polypeptide, composition and application |
| 05/29/2013 | CN102477089B Plant low-temperature resistance related protein, its encoded gene and application |
| 05/29/2013 | CN102399284B Fox growth hormone releasing hormone cDNA and its application |
| 05/29/2013 | CN102399283B Mink growth hormone releasing hormone cDNA and application thereof |
| 05/29/2013 | CN102344487B Plant resistance-related protein ATWRKY46 as well as encoding gene and application thereof |
| 05/29/2013 | CN102250227B Plant sucrose transport protein, and coding gene and application thereof |
| 05/29/2013 | CN102241755B Yield per plant associated protein and coding gene and application thereof |
| 05/29/2013 | CN102234322B Protein GmNF-YA1 related with stress tolerance of plants, and coding gene and application thereof |
| 05/29/2013 | CN102234321B Plant stress-tolerant associated protein GmNF-YB1 and encoding gene and application thereof |
| 05/29/2013 | CN102234317B Influenza A (H1N1) hemagglutinin antigen, and purpose thereof in antibody detecting reagent |
| 05/29/2013 | CN102174092B ABA (abscisic acid) and salt related protein STS1 (steroid sulfatase 1) and encoding genes and application thereof |
| 05/29/2013 | CN102161702B Method for producing human blood albumin |
| 05/29/2013 | CN102102106B Methods for modifying plant characteristics |
| 05/29/2013 | CN102050875B Extraction and purification method of TSHR (Thyroid Stimulating Hormone Receptor) |
| 05/29/2013 | CN102037124B hERG mutants and uses thereof |
| 05/29/2013 | CN102020712B Human-like collagen for vaccine stabilizing agent and production method thereof |
| 05/29/2013 | CN101962403B Method for extracting silkworm pupa protein by utilizing microwave-assisted salt solution |
| 05/29/2013 | CN101798346B Long-acting recombinant human tissue factor pathway inhibitor expressed by yeast |
| 05/29/2013 | CN101775074B Heavy metal Cu<2+> complete antigen and preparation method thereof |
| 05/29/2013 | CN101636168B Sp35 antibodies and uses thereof |
| 05/29/2013 | CN101627052B Proteins activating pro-phenoloxidase system and genes encoding the same |
| 05/29/2013 | CN101492493B Process for obtaining high efficiency human albumin for use in detoxification therapy |
| 05/29/2013 | CN101480490B Process for obtaining a concentrate of von Willebrand factor or a complex of factor VIII/von Willebrand factor and use of the same |
| 05/29/2013 | CN101454440B Probiotic strain and antimicrobial peptide derived therefrom |
| 05/29/2013 | CN101432299B House dust mite allergen |